INHERITED BREAST CANCER VIRUS TEST PACT SIGNED BY TULANE AND AUTOIMMUNE TECHNOLOGIES FOR IMMEDIATE RELEASE NEW ORLEANS, February 23, Autoimmune Technologies LLC, a New Orleans biomedical company, today announced t

First Page		Document Content
Date: 2008-01-19 00:30:45		INHERITED BREAST CANCER VIRUS TEST PACT SIGNED BY TULANE AND AUTOIMMUNE TECHNOLOGIES FOR IMMEDIATE RELEASE NEW ORLEANS, February 23, Autoimmune Technologies LLC, a New Orleans biomedical company, today announced t Add to Reading List Source URL: www.autoimmune.com Download Document from Source Website File Size: 120,76 KB Share Document on Facebook